For the Inventor, By the Inventor

Enter assignee name

Ono Pharmaceuticals Co., Ltd.

USPTO Granted Patents = 22

Forward Citations = 130

Loading Chart...

Loading Chart...

64 inventors (with patents filed for the assignee):

Shinji Nakade (3 out of 17 patents)

Hiromu Habashita (3 out of 17 patents)

Fumio Nambu (3 out of 10 patents)

4. Shuichi Ohuchida (3 out of 43 patents)

5. Tohru Kambe (2 out of 18 patents)

6. Kousuke Tani (2 out of 33 patents)

7. Toru Maruyama (2 out of 21 patents)

8. Shinsaku Yamane (2 out of 11 patents)

9. Satoshi Nakayama (2 out of 10 patents)

10. Jun Takeuchi (2 out of 23 patents)

11. Shiro Shibayama (2 out of 52 patents)

12. Takayuki Maruyama (2 out of 20 patents)

13. Masaya Kokubo (2 out of 15 patents)

14. Yoshikazu Takaoka (2 out of 23 patents)

15. Kaoru Kobayashi (2 out of 40 patents)

22 patents: Sort by Forward Citations

1. 10501442 - Quinoline derivative (2019-12-10),

2. 9403867 - Methods of producing anamorelin hydrochloride having controlled chloride content (2016-08-02),

3. 9388157 - Bicyclic compound and use thereof for medical purposes (2016-07-12),

4. 8765783 - Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation (2014-07-01),

5. 8748485 - Compound and medical use thereof (2014-06-10),

6. 8614340 - Bicyclic compound and use thereof for medical purposes (2013-12-24),

7. 8115014 - Ethynylindole compounds (2012-02-14),

8. 7968572 - Nitrogen-containing heterocyclic compound and pharmaceutical application thereof (2011-06-28),

9. 7629369 - N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation (2009-12-08),

10. 7498323 - Spiro-piperidine compounds and medicinal use thereof (2009-03-03),

11. 7300917 - Remedy for chronic disease (2007-11-27),

12. 7291644 - Indole derivatives (2007-11-06),

13. 7288558 - Pharmaceutical composition for treatment for urinary diseases comprising LPA receptor regulator (2007-10-30),

14. 7285552 - Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient (2007-10-23),

15. 7273725 - Human and mammalian stem cell-derived neuron survival factors (2007-09-25),

Ono Pharmaceuticals Co., Ltd. is a leading pharmaceutical company based in Japan. They specialize in the research, development, and production of innovative drugs to improve the quality of life for patients worldwide. With a strong focus on oncology, immunology, and neurology, Ono Pharmaceuticals is dedicated to advancing healthcare through groundbreaking therapies and solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

22 Patents

#260 in Osaka

#2,727 in Japan

#27,908 in the World

Ono Pharmaceuticals Co., Ltd.

Forward Citations = 130

64 inventors:

Shinji Nakade (3 out of 17 patents)

Hiromu Habashita (3 out of 17 patents)

Fumio Nambu (3 out of 10 patents)

4. Shuichi Ohuchida (3 out of 43 patents)

5. Tohru Kambe (2 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…